Use of famciclovir to prevent HPV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation

Journal of Hepatology

Volumn 28, Issue 3, 1998, Pages 359-368

  Lau, George K k ^a   Liang, Raymond ^a   Wu, Pui Chee ^a   Lee, Cheuk Kwong ^a   Lim, Wei Ling ^a   Au, Wing Yan ^a  

^a NONE

Author keywords

Allogeneic bone marrow transplantation; Famciclovir; Hepatitis B

Indexed keywords

FAMCICLOVIR; HEPATITIS B SURFACE ANTIGEN; NUCLEOSIDE ANALOG; 2 AMINOPURINE; ANTIVIRUS AGENT; DRUG DERIVATIVE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LEUKEMIA; LIVER FAILURE; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; VIRUS REACTIVATION; VIRUS REPLICATION; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; DRUG EFFECT; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INCIDENCE; POSTOPERATIVE PERIOD; VIRUS ACTIVATION;

2-AMINOPURINE; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INCIDENCE; MALE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 0032008570     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80307-3     Document Type: Article

References (39)

1. Hoffnagle JH, Dusheiko GM, Schafer DF, Jones EA, Micetich KC, Young RC, Costa J. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med. 96:1982;447-449.
2. Galbraith RM, Eddleston AL, Williams R, Zuckerman AJ, Bagshawe KD. Fulminant hepatic failure in leukemia and choriocacinoma related to withdrawal of cytotoxic drug therapy. Lancet. ii:1975;528-530.
3. Bird GLA, Smith H, Portmann B, Alexander GJM, Williams R. Acute liver decomposition on withdrawal of cytotoxic therapy and immunosuppressive therapy in hepatitis B carriers. Q J Med. 73:1989;895-902.
4. Lau JYN, Lai CL, Lin HJ, Lok ASF, Liang RHS, Wu PC, et al. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med. 36:1989;47-54.
5. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology. 81:1981;978-991.
6. Davis GL, Hoffnagle JH. Reactivation of chronic hepatitis B virus infection. Gastroenterology. 92:1987;2028-2031.
7. Liang RHS, Lok ASF, Lai CL, Chan TK, Todd D, Chiu KW. Hepatitis B infection in patients with lymphomas. Hematol Oncol. 8:1990;261-270.
8. Lok ASF, Liang RHS, Chiu EKW, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology. 100:1991;182-188.
9. Lau GKK, Liang RHS, Chiu EKW, Lee CK, Lam SK. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case-controlled study. Bone Marrow Transplant. 19:1997;795-799.
10. Pariente EA, Goudeau A, Dubious F, Degott C, Gluckman E, Devergie A, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci. 33:1988;1185-1191.
11. Dientstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamuvidine for chronic hepatitis B infection. N Engl J Med. 333:1995;1657-1661.
12. Main J, Brown JL, Howells C, Galassini R, Crossey M, Karayiannis P, et al. A double blind, placebo-controlled study to assess the effect of famciclovir on viral replication in patients with chronic hepatitis B virus infection. J Viral Hepatitis. 3:1996;211-215.
13. Schalm SW, de Man RA, Heitjtink RA, Niesters HGM. New nucleosides analogues for chronic hepatitis B. J Hepatol. 22:1995;52-56. (Suppl 1).
14. Kruger T, Tillman HL, Trautwein C, Oldhafer K, Boker KHW, Pichlmeyer R, et al. Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation. Hepatology. 22:1995;219A.
15. Rabinovitz M, Dodson F, Rakela J. Famciclovir for recurrent hepatitis B (HBV) infection after liver transplantation. Hepatology. 24:1996;282A.
16. Shaw T, Amor G, Civitico G, Boyd M, Locarnini S. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother. 38:1994;719-723.
17. Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine-HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 44:1987;778-783.
18. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 18:1974;295-304.
19. Beyer J, Schwella N, Zingsem J, Strohscheer I, Schwaner I, Oettle-H, et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol. 13:1995;1328-1335.
20. Lau GKK, Lok ASF, Liang RHS, Lai CL, Chiu EKW, Lau YL, et al. Clearance of HBsAg after bone marrow transplantation: role of adoptive immunity transfer. Hepatology. 25:1997;1497-1501.
21. Urdea M, Horn ST, Fultz TJ, Anderson M, Runnings JA, Hamren S, et al. Branched DNA amplification multimer for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Res Symp Ser. 24:1991;197-200.
22. Chung HT, Lok ASF, Lai CL. Re-evaluation of α-interferon treatment of chronic hepatitis B using polymerase chain reaction. J Hepatol. 17:1993;208-21.
23. Lau GKK, Davis GL, Wu PC, Gish R, Barlat LA, Lau JYN. Hepatic expression of hepatitis C virus in chronic hepatitis C: a study by in-situ reverse transcription polymerase chain reaction. Hepatology. 23:1996;1318-1323.
24. Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam CA, Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet. 348:1996;1352-1355.
25. Knodell RG, Ishak KG, Black WC, Chen T, Crag R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
26. Wu PC, Fang JWS, Lai CL, Lau SKH, Lo CK. Hepatic expression of hepatitis B virus genome in chronic hepatitis B virus infection. Am J Clin Pathol. 105:1996;87-95.
27. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA. 93:1996;4398-4402.
28. Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol. 26:1997;517-526.
29. Tur Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA. 83:1986;1627-1631.
30. Aye TT, Bartholomeusz AI, Shaw T, Bowden S, Breschkin A, McMillan J, et al. Hepatitis B virus polymerase mutation during famciclovir therapy in patients with following liver transplantation. J Hepatol. 26:1997;1148-1153.
31. Trepo C, Jezek P, Atkinson GF, Boon RJ. Efficacy of famciclovir in chronic hepatitis B: results of a dose finding study. Hepatology. 24:1996;188A.
32. Trepo C, Jezek P, Atkinson GF, Boon RJ. Long-term efficacy of famciclovir (FVC) in chronic hepatitis B: results of a phase IIB study. J Hepatol. 26:1997;74. (Suppl 1).
33. Lok ASF, Liang RH, Chung H. Recovery from hepatitis B [letter]. Ann Intern Med. 116:1992;957.
34. Ilan Y, Nagler A, Adler R, Tur-Kaspa R, Slavin S, Shouval D. Ablation of persistent hepatitis B by BMT from a hepatitis B immune donor. Gastroenterology. 104:1993;1818-1821.
35. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood. 69:1987;369-380.
36. Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, DiBisceglie AM, et al. Randomised, controlled trial of recombinant human-interferon in patients with chronic hepatitis B. Gastroenterology. 95:1988;1318-1325.
37. Lok ASF, Wu PC, Lai CL, Leung EK. Long-term follow-up in a randomised controlled trial of recombinant-interferon in Chinese patients with chronic hepatitis B virus infection. Lancet. ii:1988;298-302.
38. Alexander GJM, Fagen EA, Daniels HM, Eddleston ALWF, Williams R. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet. ii:1987;66-68.
39. Ayash LJ, Hunt M, Antman K, Nadler L, Wheeler C, Takvorian T, et al. Hepatic veno-occlusive disease in autologous bone marrow transplantation of solid tumors and lymphoma. J Clin Oncol. 8:1990;1699-1706.